We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moleculin Biotech Inc | TG:MOL | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Jul 2019 to Jul 2024
FRANKFURT: German utility RWE AG (RWE.XE) is poised to exit the Nabucco gas pipeline project, according to a report in weekly Focus magazine, citing persons in the industry.
RWE may sell its 16.6% stake in the project to Austrian oil and gas company OMV AG (OMV.VI) and the deal may be completed by year end, the article says.
In October OMV Chief Executive Gerhard Roiss said that the Nabucco consortium, which includes OMV, remained open to more participants. He repeated earlier comments that there were no indications that the Hungarian partner MOL Nyrt. (MOL.BU) would withdraw from the Nabucco consortium. When completed, the pipeline will feed natural gas from the Caspian Sea region to Europe.
An RWE spokeswoman declined to comment to Dow Jones on the report.
Write to the Frankfurt Bureau at djnews.frankfurt@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Moleculin Biotech Chart |
1 Month Moleculin Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
